Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Journal of Immunology Research, enter your email address in the box below.

Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 785627, 4 pages
http://dx.doi.org/10.1155/2012/785627
Review Article

Autoimmunity and Extrahepatic Manifestations in Treatment-Naïve Children with Chronic Hepatitis C Virus Infection

Giuseppe Indolfi,1 Elisa Bartolini,1 Biagio Olivito,2 Chiara Azzari,2 and Massimo Resti1

1Paediatric and Liver Unit, Meyer Children University Hospital of Florence, Italy
2Immunology Unit and Immunology Laboratory, Meyer Children University Hospital of Florence, Department of Sciences for Woman and Child's Health, University of Florence, Florence, Italy

Received 4 January 2012; Accepted 21 February 2012

Academic Editor: Domenico Sansonno

Copyright © 2012 Giuseppe Indolfi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Q. L. Choo, G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton, “Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome,” Science, vol. 244, no. 4902, pp. 359–362, 1989. View at Google Scholar · View at Scopus
  2. A. L. Zignego, C. Ferri, S. A. Pileri, P. Caini, and F. B. Bianchi, “Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach,” Digestive and Liver Disease, vol. 39, no. 1, pp. 2–17, 2007. View at Publisher · View at Google Scholar
  3. F. Bortolotti, P. Vajro, F. Balli et al., “Non-organ specific autoantibodies in children with chronic hepatitis C,” Journal of Hepatology, vol. 25, no. 5, pp. 614–620, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. G. V. Gregorio, P. Pensati, R. Iorio, A. Vegnente, G. Mieli-Vergani, and D. Vergani, “Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection,” Clinical and Experimental Immunology, vol. 112, no. 3, pp. 471–476, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Muratori, L. Muratori, G. Verucchi, L. Attard, F. B. Bianchi, and M. Lenzi, “Non-organ-specific autoantibodies in children with chronic Hepatitis C: clinical significance and impact on interferon treatment,” Clinical Infectious Diseases, vol. 37, no. 10, pp. 1320–1326, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Gehring, U. Kullmer, S. Koeppelman, P. Gerner, P. Wintermeyer, and S. Wirth, “Prevalence of autoantibodies and the risk of autoimmune thyroid disease in children with chronic hepatitis C virus infection treated with interferon-α,” World Journal of Gastroenterology, vol. 12, no. 36, pp. 5787–5792, 2006. View at Google Scholar · View at Scopus
  7. D. P. Bogdanos, G. Mieli-Vergani, and D. Vergani, “Non-organ-specific autoantibodies in hepatitis C virus infection: do they matter?” Clinical Infectious Diseases, vol. 40, no. 4, pp. 508–510, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. H. T. Maecker, M. S. Do, and S. Levy, “CD81 on B cells promotes interleukin 4 secretion and antibody production during T helper type 2 immune responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 5, pp. 2458–2462, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. D. P. Bogdanos, G. Mieli-Vergani, and D. Vergani, “Virus, liver and autoimmunity,” Digestive and Liver Disease, vol. 32, no. 5, pp. 440–446, 2000. View at Google Scholar · View at Scopus
  10. T. Stroffolini, G. Colloredo, G. B. Gaeta et al., “Does an “autoimmune” profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey,” Journal of Viral Hepatitis, vol. 11, no. 3, pp. 257–262, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Muratori, L. Muratori, M. Guidi et al., “Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C,” Clinical Infectious Diseases, vol. 40, no. 4, pp. 501–507, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Bortolotti, L. Muratori, P. Jara et al., “Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children,” Journal of Pediatrics, vol. 142, no. 2, pp. 185–190, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Indolfi, S. Stagi, E. Bartolini et al., “Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection,” Clinical Endocrinology, vol. 68, no. 1, pp. 117–121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Rago, L. Chiovato, L. Grasso, A. Pinchera, and P. Vitti, “Thyroid ultrasonography as a tool for detecting thyroid autoimmune diseases and predicting thyroid dysfunction in apparently healthy subjects,” Journal of Endocrinological Investigation, vol. 24, no. 10, pp. 763–769, 2001. View at Google Scholar · View at Scopus
  15. J. Bartolomé, E. Rodríguez-Iñigo, P. Quadros et al., “Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection,” Journal of Medical Virology, vol. 80, no. 9, pp. 1588–1594, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Sugiura, T. Yamada, Y. Kimpara, N. Fujita, K. Goto, and N. Koyama, “Effects of pegylated interferon α-2a on hepatitis-C-virus-associated glomerulonephritis,” Pediatric Nephrology, vol. 24, no. 1, pp. 199–202, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Matsumoto, S. Nakajima, K. Nakamura et al., “Interferon treatment on glomerulonephritis associated with hepatitis C virus,” Pediatric Nephrology, vol. 15, no. 3-4, pp. 271–273, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Romas, D. A. Power, D. Machet, H. Powell, and A. J. F. D'Apice, “Membranous glomerulonephritis associated with hepatitis C virus infection in an adolescent,” Pathology, vol. 26, no. 4, pp. 399–402, 1994. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Mohan, R. S. Chandra, D. M. Escolar, and N. L. C. Luban, “Inflammatory myopathy and hepatitis C in a pediatric patient: role of liver biopsy in evaluating the severity of liver disease,” Hepatology, vol. 34, no. 4, pp. 851–852, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. J. I. Satoh, Y. I. Eguchi, T. Narukiyo et al., “Necrotizing myopathy in a patient with chronic hepatitis C virus infection: a case peport and a review of the literature,” Internal Medicine, vol. 39, no. 2, pp. 176–181, 2000. View at Google Scholar · View at Scopus
  21. V. Ertekin and H. Tan, “Opsoclonus-myoclonus syndrome attributable to Hepatitis C infection,” Pediatric Neurology, vol. 42, no. 6, pp. 441–442, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. E. J. Dropcho, “Update on paraneoplastic syndromes,” Current Opinion in Neurology, vol. 18, no. 3, pp. 331–336, 2005. View at Google Scholar · View at Scopus
  23. Z. Kayali, V. E. Buckwold, B. Zimmerman, and W. N. Schmidt, “Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis,” Hepatology, vol. 36, no. 4, pp. 978–985, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Bortolotti, G. Verucchi, C. Cammà et al., “Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease,” Gastroenterology, vol. 134, no. 7, pp. 1900–1907, 2008. View at Publisher · View at Google Scholar